EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center
ST. PAUL, Minn., May 18, 2017 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today a... Devices, Neurology EnteroMedics, vBloc , Neurometabolic Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Eating Disorders & Weight Management | Gastroenterology | Marketing | Medical Devices | Neurology | Obesity | Pharmaceuticals